Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

RxSight (RXST) Non-Current Assets (2020 - 2025)

RxSight (RXST) has disclosed Non-Current Assets for 6 consecutive years, with $24.4 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Non-Current Assets fell 1.56% year-over-year to $24.4 million, compared with a TTM value of $98.8 million through Dec 2025, up 13.12%, and an annual FY2025 reading of $24.4 million, down 1.56% over the prior year.
  • Non-Current Assets was $24.4 million for Q4 2025 at RxSight, down from $24.7 million in the prior quarter.
  • Across five years, Non-Current Assets topped out at $25.1 million in Q2 2025 and bottomed at $13.9 million in Q3 2023.
  • Average Non-Current Assets over 5 years is $19.0 million, with a median of $16.8 million recorded in 2022.
  • The sharpest move saw Non-Current Assets decreased 15.96% in 2023, then surged 74.93% in 2024.
  • Year by year, Non-Current Assets stood at $16.4 million in 2021, then fell by 4.97% to $15.6 million in 2022, then decreased by 9.39% to $14.1 million in 2023, then soared by 74.93% to $24.7 million in 2024, then fell by 1.56% to $24.4 million in 2025.
  • Business Quant data shows Non-Current Assets for RXST at $24.4 million in Q4 2025, $24.7 million in Q3 2025, and $25.1 million in Q2 2025.